Astral Systems logo

Astral Systems

Develops deep-tech systems for commercialising medical isotopes, using its Series A funding to advance deployment from Bristol.

Deep Tech
Medical Isotopes
Total Raised
$26M
Last Valuation
$130M
Headquarters
Bristol, United Kingdom

Overview

Astral Systems is a Bristol-based deep-tech company focused on commercialising medical isotopes. Its work targets the medical-isotope market, supporting healthcare and life-science customers that depend on reliable isotope availability. The company’s positioning centers on translating isotope-related systems into commercial supply, rather than operating as an AI vendor. Astral Systems raised a reported €26 million Series A in June 2026, listed as $26 million total funding, to support medical isotope commercialisation.

Funding History

1 round · Jun 2026
$26M
Total Raised
1
Valuation: $130M
Cumulative: $26M

Bristol’s Astral Systems secures €26 million Series A to support medical isotope commercialisation

Investors not disclosed
Source

Frequently Asked Questions

How much has Astral Systems raised in total?
Astral Systems has raised a total of $26M across 1 funding round.
Who are Astral Systems's investors?
Astral Systems's investors include Undisclosed.
What does Astral Systems do?
Astral Systems is a Bristol-based deep-tech company focused on commercialising medical isotopes. Its work targets the medical-isotope market, supporting healthcare and life-science customers that depend on reliable isotope availability. The company’s positioning centers on translating isotope-related systems into commercial supply, rather than operating as an AI vendor. Astral Systems raised a reported €26 million Series A in June 2026, listed as $26 million total funding, to support medical isotope commercialisation.
Where is Astral Systems headquartered?
Astral Systems is headquartered in Bristol, United Kingdom.